Abstract
To flatten the curve of the natural epidemic of covid-19, many countries adopted lockdown or isolation resulting in the containment of the SARS-CoV-2 transmission. However, an important question arises about the strategies of release of isolated persons to avoid overloaded hospitals and increased deaths. São Paulo State (Brazil) implemented the isolation of the population in non-essential activities on March 24, and the progressive flexibilization considering the characteristics of each location (release of the isolated population) initiated on June 15. A mathematical model based on the natural history of covid-19 was applied to describe the epidemiological scenario with isolation in São Paulo State, and assess the impact of release on the covid-19 epidemic. Using data collected from São Paulo State, we estimated the model parameters to obtain the curves of the epidemic, the number of deaths, and the clinical evolution of covid-19. The epidemic under isolation was the framework to evaluate the strategies of the release, that is, how these curves are changed with the release of isolated persons. We evaluated three strategies of release. First two strategies considered four releases in the isolated population in four equal proportions, but successive releases elapsed by 14 and 21 days. In each strategy the beginning of the release was on June 29 and July 13, when the effective reproduction number Ref was evaluated. The third strategy aimed at the protection of the elder subpopulation. We observed that the delay to begin the release and the increased elapse between successive releases resulted in a better scenario by decreasing severe covid-19 cases and, consequently, to avoid overloaded hospitals. We also observed that the release delayed to achieve lower values for Ref and infectious persons retarded in several months the quick increasing phase of the forthcoming epidemic. However, this epidemic can be flattened or even suppressed by isolation of infectious persons by mass testing and/or by rigid adoption of protective measures and social distancing.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
There was no funding support.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
None
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Data Availability
Data collected from São Paulo State government.
